ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of inflammasome activation via sphingolipid pathway in acute lung injury by Huanglian Jiedu decoction: An integrative pharmacology approach

Chen, Ying; Peng, Mingming; Li, Wei; Zhao, Mantong; Cao, Xia; Li, Chuanqiu; Zhang, Han; Yang, Mengru; Liang, Lanyuan; Yue, Yiming; Xia, Tianyi; Zhong, Renxing; Wang, Yi; Shu, Zunpeng*广东药学院
PHYTOMEDICINE2022-12DOI: 10.1016/j.phymed.2022.154469
8被引32阅读
引用收藏
分享

摘要

Background: Acute lung injury (ALI) is a serious health issue which causes significant morbidity and mortality. Inflammation is an important factor in the pathogenesis of ALI. Even though ALI has been successfully managed using a traditiomal Chinese medicine (TCM), Huanglian Jiedu Decoction (HLD), its mechanism of action remains unknown. @@@ Purpose: This study explored the therapeutic potential of HLD in lipopolysaccharide (LPS)-induced ALI rats by utilizing integrative pharmacology. @@@ Methods: Here, the therapeutic efficacy of HLD was evaluated using lung wet/dry weight ratio (W/D), myeloperoxide (MPO) activity, and levels of tumor necrosis factor (TNF-alpha), interleukin (IL)-1 beta and IL-6. Network pharmacology predictd the active components of HLD in ALI. Lung tissues were subjected to perform Hematoxylin-eosin (H&E) staining, metabolomics, and transcriptomics. The acid ceramidase (ASAH1) inhibitor, carmofur, was employedto suppress the sphingolipid signaling pathway. @@@ Results: HLD reduced pulmonary edema and vascular permeability, and suppressed the levels of TNF-alpha, IL-6, and IL-1 beta in lung tissue, Bronchoalveolar lavage fluid (BALF), and serum. Network pharmacology combined with transcriptomics and metabolomics showed that sphingolipid signaling was the main regulatory pathway for HLD to ameliorate ALI, as confirmed by immunohistochemical analysis. Then, we reverse verified that the sphingo-lipid signaling pathway was the main pathway involed in ALI. Finally, berberine, baicalein, obacunone, and geniposide were docked with acid ceramidase to further explore the mechanisms of interaction between the compound and protein. @@@ Conclusion: HLD does have a better therapeutic effect on ALI, and its molecular mechanism is better elucidated from the whole, which is to balance lipid metabolism, energy metabolism and amino acid metabolism, and inhibit NLRP3 inflammasome activation by regulating the sphingolipid pathway. Therefore, HLD and its active components can be used to develop new therapies for ALI and provide a new model for exploring complex TCM systems for treating ALI.

学科与关键词

关键词
Acute lung injuryHuanglian Jiedu DecoctionIntegrating pharmacologySphingolipid pathwayNLRP3 inflammasome
相关
加载中…
  • Biomarkers, signaling pathways, and programmed cell death in acute lung injury and its treatment with Traditional Chinese Medicine: a narrative review
    An, Y.; Zhang, H.; Wang, R.; Shen, Y. -F.; Zhao, J. -L.*; Zou, Y. -S.*; Wang, G. -Z.*European Review for Medical and Pharmacological Sciences, 2023, 27(21): 10157-10170.
  • Integrated Pharmacology Reveals the Molecular Mechanism of Gegen Qinlian Decoction Against Lipopolysaccharide-induced Acute Lung Injury
    Li, Wei; Ding, Zihe; Chen, Ying; Wang, Yi; Peng, Mingming; Li, Chuanqiu; Zhang, Han; Zhong, Renxing; Xia, Tianyi; Zhong, Luyang; Zhao, Mantong; Yang, Mengru; Yue, Yimin; Liang, Lanyuan; Cao, Xia; Shu, Zunpeng*Frontiers in Pharmacology, 2022, 13: 854544.被引 5
  • Monochasma savatieri Franch. protects against acute lung injury via α7nAChR-TLR4/NF-κB p65 signaling pathway based on integrated pharmacology analysis
    Zhao, Mantong; Yang, Mengru; Du, Jieyong; Cao, Xia; Zhong, Luyang; Li, Wei; Chen, Ying; Peng, Mingming; Guo, Huilin; Zhou, Tong; Zhang, Chongyang; Ren, Zhonglu; Ding, Zihe; Zhong, Renxing; Wang, Yi*; Shu, Zunpeng*Journal of Ethnopharmacology, 2024, 321: 117487.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-12
卷期
第 107 卷
页码
154469
DOI
10.1016/j.phymed.2022.154469
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82141211, 82174043]; Guangdong Basic and Applied Basic Research Foundation [2021A1515011697]; 2021 High tech industrialization entrepreneurship team project of Foshan Hightech Zone [2120197000214]; Innovation and entrepreneurship team project [2130218004133]

作者

  • C

    Chen, Ying (第一作者)

    guangdong pharmaceut univ

  • P

    Peng, Mingming

    guangdong pharmaceut univ

查看全部 14 位作者收起作者
  • L

    Li, Wei

    guangdong pharmaceut univ

  • Z

    Zhao, Mantong

    guangdong pharmaceut univ

  • C

    Cao, Xia

    guangdong pharmaceut univ

  • L

    Li, Chuanqiu

    guangdong pharmaceut univ

  • Z

    Zhang, Han

    jiamusi univ

  • Y

    Yang, Mengru

    guangdong pharmaceut univ

  • L

    Liang, Lanyuan

    guangdong pharmaceut univ

  • Y

    Yue, Yiming

    guangdong pharmaceut univ

  • X

    Xia, Tianyi

    guangdong pharmaceut univ

  • Z

    Zhong, Renxing

    guangdong pharmaceut univ

  • W

    Wang, Yi

    guangdong pharmaceut univ

  • S

    Shu, Zunpeng (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417